Stocks · Health care · Pharmaceutical Preparations

Sarepta Therapeutics, Inc.

SRPT Clue Score48
United States Fiscal year ends December CIK 0000873303 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Stephen Mayo
12 Mar 2026
Director
Sell
7,239
$17.02
$123.21K
Ian Michael Estepan
26 Feb 2026
Chief Operating Officer
Exercised, kept
5,381
$13.71
$73.77K
Ian Michael Estepan
26 Feb 2026
Chief Operating Officer
Exercised, kept
2,069
$13.71
$28.37K
Claude Nicaise
29 Jan 2026
Director
Exercised, kept
10,500
$13.71
$143.96K
M Kathleen Behrens
27 Jan 2026
Director
Exercised, kept
10,500
$13.71
$143.96K
Ian Michael Estepan
16 Dec 2025
Chief Operating Officer
Sell
13,187
$22.31
$294.20K

What was left out

Form 4 filings counted 37
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 1,591,567
History held since 8 Feb 2007